Miguel Angel Martinez (Miguel A Martinez, Miguel A Martínez)

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 14

Top Venues

Antimicrobial agents and chemotherapy

Viruses

Journal of virology

Microorganisms

IrsiCaixa Institut de Recerca de la Sida

Universidad Autónoma de Madrid (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

IrsiCaixa Institut de Recerca de la Sida Jan 01 1997

Spain

Senior Researcher :: Retrovirology

Universidad Autonoma de Madrid Centro de Biología Molecular Severo Ochoa May 01 1995 - Dec 31 1996

Spain

Postdoctoral fellow :: Viurs Variability

Institut Pasteur Oct 01 1992 - Apr 30 1995

France

Postdoctoral fellow :: Retrovirology

Universidad Autonoma de Madrid Centro de Biología Molecular Severo Ochoa Dec 01 1990 - Sep 30 1992

Spain

Postdoctoral fellow :: Virus Varibility

Institute for Animal Health Aug 01 1990 - Nov 30 1990

United Kingdom

Postdoctoral fellow :: Foot-and-mouth disease virus Reference Laboratory

Instituto Nacional de Investigaciones Agrarias (INIA) Oct 01 1984 - Jul 31 1990

Spain

Ph.D Student :: Departamento de Sanidad Animal

Education History

Universidad Autónoma de Madrid - Jul 07 1989

Spain

PHD :: Biology

Universidad Autónoma de Madrid - Jun 01 1982

Spain

BSC :: Biology

Publications

Sandra Franco, Lourdes Mateu, Raquel Pluvinet, José Francisco Sánchez-Herrero, Ruth Toledo, Lauro Sumoy, Marta Massanella, Miguel Angel Martinez
Altered Plasma microRNA Signature in Hospitalized COVID-19 Patients Requiring Oxygen Support. Microorganisms 12 (3) (2024)
Sandra Franco, Lourdes Mateu, Raquel Pluvinet, José Francisco Sánchez-Herrero, Ruth Toledo, Lauro Sumoy, Marta Massanella, Miguel Angel Martinez
Altered Plasma microRNA Signature in Hospitalized COVID-19 Patients Requiring Oxygen Support. Microorganisms 12 (3) (2024)
Miguel Angel Martinez, Cristina Tural, Sandra Franco
Circulating MicroRNAs as a Tool for Diagnosis of Liver Disease Progression in People Living with HIV-1. Viruses 14 (6) (2022)
Miguel Angel Martinez
Diversity and Evolution of HIV and HCV. Viruses 13 (4) (2021)
Miguel Angel Martinez, Sandra Franco
Impact of COVID-19 in Liver Disease Progression. Hepatology communications 5 (7) (2021)
Ana Jordan-Paiz, Sandra Franco, Miguel Angel Martinez
Synonymous Codon Pair Recoding of the HIV-1 env Gene Affects Virus Replication Capacity. Cells 10 (7) (2021)
Miguel Angel Martinez
Plitidepsin: a Repurposed Drug for the Treatment of COVID-19. Antimicrobial agents and chemotherapy 65 (4) (2021)
Miguel Angel Martinez, Sandra Franco
Therapy Implications of Hepatitis C Virus Genetic Diversity. Viruses 13 (1) (2020)
Miguel Angel Martinez
Clinical Trials of Repurposed Antivirals for SARS-CoV-2. Antimicrobial agents and chemotherapy 64 (9) (2020)
Ana Jordan-Paiz, Maria Nevot, Kevin Lamkiewicz, Marie Lataretu, Sandra Franco, Manja Marz, Miguel Angel Martinez
HIV-1 Lethality and Loss of Env Protein Expression Induced by Single Synonymous Substitutions in the Virus Genome Intronic-Splicing Silencer. Journal of virology 94 (21) (2020)
Miguel Angel Martinez
Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus. Antimicrobial agents and chemotherapy 64 (5) (2020)
Roger Badia, Ester Ballana, Marc Castellví, Edurne García-Vidal, Maria Pujantell, Bonaventura Clotet, Julia G Prado, Jordi Puig, Miguel Angel Martinez, Eva Riveira-Muñoz, José A Esté
CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir. Nature communications 9 (1) (2018)
Maria Nevot, Ana Jordan-Paiz, Glòria Martrus, Cristina Andrés, Damir García-Cehic, Josep Gregori, Sandra Franco, Josep Quer, Miguel Angel Martinez
HIV-1 Protease Evolvability Is Affected by Synonymous Nucleotide Recoding. Journal of virology 92 (16) (2018)
Annalaura Brai, Roberta Fazi, Cristina Tintori, Claudio Zamperini, Francesca Bugli, Maurizio Sanguinetti, Egidio Stigliano, José Esté, Roger Badia, Sandra Franco, Miguel Angel Martinez, Javier P Martinez, Andreas Meyerhans, Francesco Saladini, Maurizio Zazzi, Anna Garbelli, Giovanni Maga, Maurizio Botta
Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents. Proceedings of the National Academy of Sciences of the United States of America 113 (19) (2016)

Miguel Angel Martinez.css-eqlu8i{font-size:small;padding-left:4px;} (Miguel A Martinez, Miguel A Martínez)

Publication Activity (10 Years)

Top Topics

Top Venues

Miguel Angel Martinez (Miguel A Martinez, Miguel A Martínez)